The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and Phosphatases
Abstract
Protein phosphorylation is one of the major regulatory mechanisms involved in signal-induced cellular events, including cell proliferation, apoptosis, and metabolism. Because many facets of biology are regulated by protein phosphorylation, aberrant kinase and/or phosphatase activity forms the basis for many different types of pathology. The disease relevance of protein kinases and phosphatases has led many pharmaceutical and biotechnology companies to expend significant resources in lead discovery programs for these two target classes. The existence of >500 kinases and phosphatases encoded by the human genome necessitates development of methodologies for the rapid screening for novel and specific compound inhibitors. We describe here a fluorescence-based, molecular assay platform that is compatible with robotic, ultra-high throughput screening systems and can be applied to virtually all tyrosine and serine/threonine protein kinases and phosphatases. The assay has a coupled-enzyme format, utilizing the differential protease sensitivity of phosphorylated versus nonphosphorylated peptide substrates. In addition to screening individual kinases, the assay can be formatted such that kinase pathways are re-created in vitro to identify compounds that specifically interact with inactive kinases. Miniaturization of this assay format to the 1-microl scale allows for the rapid and accurate compound screening of a host of kinase and phosphatase targets, thereby facilitating the hunt for new leads for these target classes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Cited by
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Medintz, I. L., Clapp, A. R., Brunel, F. M., Tiefenbrunn, T., Tetsuo Uyeda, H., Chang, E. L., Deschamps, J. R., Dawson, P. E., & Mattoussi, H. (2006) · Nature Materials · doi:10.1038/nmat1676 · Cited by 550
ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for Kinases
Zegzouti, H., Zdanovskaia, M., Hsiao, K., & Goueli, S. A. (2009) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2009.0222 · Cited by 273
Metadata
- Authors
- Rodems, S. M., Hamman, B. D., Lin, C., Zhao, J., Shah, S., Heidary, D., Makings, L., Stack, J. H., & Pollok, B. A.
- Venue
- ASSAY and Drug Development Technologies
- Publisher
- SAGE Publications
- Published
- 2002-11
- Volume
- 1
- Issue
- 1
- Pages
- 9-19
- ISSN
- 1540-658X (ISSN-L)
- 1557-8127
- OpenAlex
- W2111017461
- Cited by
- 160
- References
- 2
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and Phosphatases. https://app.cochat.ai/papers/10.1089/154065802761001266
- The paper
- Rodems, S. M., Hamman, B. D., Lin, C., Zhao, J., Shah, S., Heidary, D., Makings, L., Stack, J. H., & Pollok, B. A. (2002). A FRET-Based Assay Platform for Ultra-High Density Drug Screening of Protein Kinases and Phosphatases. ASSAY and Drug Development Technologies. https://doi.org/10.1089/154065802761001266
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.